| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.1 |